Xin Chen

Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling

F. Tan, Q. Xue, Shan Yang, 2022, EBioMedicine.

Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics

R. Liu, Xue Wu, Y. Shao, 2021, Hepatology.

Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation

Q. Ou, Shanshan Zhao, Man Li, 2021, OncoTargets and therapy.

OTT_A_334847 5353..5360

Q. Ou, Shanshan Zhao, Man Li, 2021 .

Clinicopathological and molecular characteristics of the alpha‐fetoprotein–producing gastric cancer: emphasis on two major subtypes

Y. Shao, M. Jin, Jun Lu, 2021, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer

Yong Liu, Y. Shao, Wei Zhao, 2022, Thoracic cancer.

Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment

A. Nagler, He Huang, Y. Shao, 2021, Journal of Cancer.

Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer

Shan Yang, Xue Wu, Y. Shao, 2022, American journal of respiratory and critical care medicine.

Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection

F. Tan, Q. Xue, Shan Yang, 2022, Molecular cancer.